“Incidence of Adverse Events in Patients With Metastatic Breast Cancer During Use of Standard and on Off Capecitabine Protocols”. 2022. Research, Society and Development 11 (8): e3711830426. https://doi.org/10.33448/rsd-v11i8.30426.